Moullan, Norman
Asiago, Josephat
Stecco, Kathryn
Hadi, Salah
Albizem, Moetaz
Tieu, Holly
Hock, Björn
Fenwick, Craig
Lin, Kai
Lengsfeld, Thomas
Poffenbarger, Lauren
Liu, David
Trono, Didier
Pantaleo, Giuseppe
Venkayya, Rajeev
Bhuyan, Prakash http://orcid.org/0000-0003-1937-9658
Funding for this research was provided by:
Aerium Therapeutics
Article History
Received: 10 November 2023
Accepted: 14 December 2023
First Online: 14 January 2024
Declarations
:
: Norman Moullan, Josephat Asiago, Kathryn Stecco, Moetaz Albizem, Holly Tieu, Kai Lin, Thomas Lengsfeld, Lauren Poffenbarger, David Liu, Rajeev Venkayya, Björn Hock and Prakash Bhuyan are employees of or former employees and hold or may hold stock in Aerium Therapeutics. Craig Fenwick, Didier Trono, and Giuseppe Pantaleo are inventors on patent applications PCT/IB2021/050621 that covers AER001/AER002 (P5C3/P2G3) and is entitled “Neutralizing antibodies and use thereof in the treatment of SARS-CoV-2 infection”. Salah Hadi has no conflicts of interest to disclose.
: The study protocol and informed consent documentation were reviewed and approved by Stichting Beoordeling Ethiek Biomedisch Onderzoek, an independent medical research ethics committee (MREC). Informed consent was obtained from all study participants included in the study. The study protocol and informed consent form were reviewed and approved by the Netherlands National Ethics Committee (EC), known as the Central Committee on Research involving Human Subjects. We further confirm that any aspect of the work covered in this manuscript that has involved human patients has been conducted with the ethical approval of all relevant bodies.